Dr. Lee is an advisory member of TCUBEit. He is serving as the CEO of Speegen Bio Inc., which develops diagnostic tools for infectious diseases. He worked as a Postdoctoral Associate at both Massachusetts General Hospital and Harvard Medical School, then serving as a Senior Biological Scientist at the University of Florida. During his stay in the U.S., he studied how iNKT cells play a role in regulatory T cell generation which recover autoimmune diseases, i.e, Type I diabetes, rheumatoid arthritis, Lyme disease, systemic lupus erythematosus, and autoimmune pancreatitis, etc.
He received his B.S, M.S., and Ph.D. in Microbiology and Molecular Biology from Kyung Hee University, South Korea. He served as a research fellow developing diagnostic tools and vaccines for the Korea Center for Disease Control for over ten years. In addition, he developed a new strategy to treat AIDS patients based on gene therapy.